# Registry Study in MSI/dMMR Solid Tumors

> **NCT06004713** · — · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 190 (estimated)

## Conditions studied

- DMMR Cancer
- MSI-H
- Solid Tumor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06004713
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-07
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004713, "Registry Study in MSI/dMMR Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06004713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*